Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novel amidino derivatives and their use as NOS inhibitors reported by Searle

Jan. 21, 2000

Vasogen to begin clinical trial with VAS-991 for treatment of congestive heart failure

Jan. 20, 2000

Potassium channel inhibitors for arrhythmias emerge from ICAgen/Lilly collaboration

Jan. 20, 2000

Efforts at DuPont to design potent and selective alphavbeta3 antagonists successful

Jan. 19, 2000

Avant Immunotherapeutics reports on TP-10 progress

Jan. 19, 2000

Pre- and postischemic treatment with FR-183998 cardioprotective in rat models

Jan. 18, 2000

Sangamo and Baxter to collaborate on novel vascular disease therapeutics

Jan. 18, 2000

Avant Immunotherapeutics updates progress with CETi-1

Jan. 18, 2000

Collateral Therapeutics boosts cardiovascular gene therapy portfolio with new patent

Jan. 17, 2000

Health Canada grants priority review to Vanlev

Jan. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...